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Abstract 
 
            Ehrlichia chaffeensis is a Gram-negative, obligatorily intracytoplasmic bacterium 
and the causative agent of a tick-borne disease, human monocytic ehrlichiosis.  In vertebrates, E. 
chaffeensis exhibits tropism for monocytes /macrophages.  However, no clear requirements for 
cell tropism have been defined in ticks.  Previously, our group identified two host genes that 
control E. chaffeensis replication in vivo in Drosophila.  We used these two genes, CG6364 and 
separation anxiety (san) to test the hypothesis that E. chaffeensis replicates in arthropod 
hemocytes.  Using the UAS/GAL4 RNAi system, we generated F1 flies (RNAi flies) and 
confirmed ubiquitous-or tissue-specific reduction in the transcript levels of the targeted genes.  
When RNAi flies were screened for Ehrlichia infections, we found that when either CG6364 or 
san were specifically suppressed in the hemocytes or in the fat body E. chaffeensis failed to 
replicate or cause infection.   Deletion of these genes in the eyes, wings or the salivary glands did 
not impact fly susceptibility or bacterial replication within these organs.  Our data demonstrate 
that in Drosophila, E. chaffeensis replicates within the hemocytes, the insect homolog of 
mammalian macrophages, and in the fat body, the liver homolog of mammals.  This study 
provides insights about replication sites of E. chaffeensis in arthropods.    
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Chapter 1 - Literature Review 
 Drosophila melanogaster 
 As an experimental model system to study host-pathogen interactions 
 An understanding of host- pathogen interactions requires a wide range of genetically 
amenable organisms and tools for forward and reverse genetics.  We can use these model 
systems to understand mechanisms that have been conserved through evolution in lower 
organisms to help us decipher intricate host-pathogen mechanisms applicable to mammalian 
systems. 
 
One powerful system which has been exploited is the fruit fly, Drosophila melanogaster. 
In the past decade, the fruit fly has been used to help us understand many aspects of innate 
immunity (77).  Drosophila spend their entire life cycle in decaying organic matter.  This 
lifestyle results in contact with an array of micro-organisms; some of them pathogenic.  
Drosophila have developed powerful mechanisms to protect itself from an environment rich with 
micro-organisms (77). 
 
The Drosophila system also fulfils other prerequisites to be considered the foremost 
experimental model system.  The generation time of the fly is short (13). The entire life cycle of 
Drosophila lasts approximately 12-13 days from forming eggs to hatching to an adult fly (13).  
Moreover, their growth is temperature dependent (13).  At 25
o
C their life cycle is 10 days, at 
room temperature (21
o
C -22
o
C) it is 12-13 days, and at 18
o
C the generation time is 19 days (13).  
Rearing and maintenance is simple and inexpensive.  Females have a high fertility rate and can 
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lay about 2000 eggs in a lifetime (13, 49).  The Drosophila genome has been sequenced and is 
one of the most fully annotated eukaryotic genomes (8).  This provides a vast source of 
information regarding the molecular makeup of the organisms and allows for functional and 
comparative genomics.  Information about all genes is annotated.  Their description expression 
profile and mutant availability is available at the Genome Annotation Database 
(http://flybase.net/annot/).  The function of human genes can be revealed by studying their 
parallels in model organisms.  Thus, it becomes an appropriate, unparalleled model system to 
investigate human diseases.  
 
 
 As a model to decipher bacterial virulence factor 
Different strategies have been used to infect flies.  For example pricking the insect body 
with a sharp needle dipped in a bacteria culture can cause disease and even death (17, 77).  
Another more refined method is microinjection of a precise dose volume allows for carefully 
controlled infections (78).  Both these methods allow activation of microbe-specific immune 
responses which can be monitored (17).  Other methods of infection include feeding flies with 
bacteria mixed in food or spraying fungal spores onto the exoskeleton (17, 78).  These methods 
resemble the natural environment and natural infection routes.  However, only few microbes are 
known to elicit an immune response in this way.  One such bacterial species that induce 
Drosophila immune responses in the absence of physical injury is Erwinia carotovara (17). 
                 
Several groups have used Drosophila as a surrogate model system to study the complex 
interplay between host and pathogen (17, 25, 35, 40, 83, 86, 95, 121, 129).  Fruit flies have been 
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successfully used to identify several virulence factors (35, 40, 72).  For example Pseudomonas 
aeruginosa is highly pathogenic to fruit flies.  Drosophila use the pil-chp transduction system 
which potentially encodes proteins involved in signal transduction pathway to regulate 
expression of virulence factors  important to controlling infection (35).  These genes are known 
to be also required for twitching and motility (35).  Studies have also suggested that that the pil-
chp transduction system is likely to be important for virulence in mammals (66).  P. aeruginosa 
virulence determinants important for mammalian pathogenesis were also cause fly death (30, 
52).   Flies were also instrumental in helping identify a Rho gap Gtpase toxin which, when 
injected by the type III secretion system, impaired hemocyte phagocytosis (14).  Since, 
hemocytes share functional similarities with human leukocytes, flies can help in the discovery of 
mammalian homologs (14).  D. melanogaster were also used to identify virulence factors of 
Serratia marcesens.  Thoracic injections of 50-100 CFU of the DB11 strain caused 100% death 
within 24h at 20
o
C (72).  Three bacterial mutants with decreased pathogenicity, were also 
identified (72).  In fact, one mutant was also markedly attenuated in a murine lung infection 
model demonstrating processes in flies may also be applicable to vertebrate models (72).  
Drosophila have also helped in identifying virulence factors of Mycobacteria.  Mycobacterium 
muranium causes tuberculosis in fish and frogs (32, 112).  In flies, it caused infections that 
resembled M.tuberculosis infections in humans (40).   
 
M. muranium infections in adult flies were lethal within eight days and killing of flies is 
accompanied by widespread tissue damage (40).  M. muranium accumulated in plasmocytes and 
did not co-localize with acidified organelles or internalized, dead E. coli suggesting successful 
macrophage subversion by M. Muranium (40).  A mag24 deficient mutant strain of the bacteria, 
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was less virulent (40).  The ability of M. muranium to reside in non acidified vacules has also 
been shown in vertebrate macrophages (15). This demonstrates that fly hemocytes are 
comparable to macrophages and that fruit flies provide insights to the understanding of human 
pathogens.  Altogether, these studies exemplify the use of Drosophila as a useful and a tractable 
model system to study bacteria-host pathogen relationships and cellular interactions in infected 
cells. 
 
 
 RNA interference in Drosophila and mechanism of gene silencing by dsRNA 
            In 1998 Fire and Mello discovered that dsRNA triggered a reduction in protein synthesis 
in Caenorhabditis elegans (53).  Clemens et al. reported a similar phenomenon in Drosophila 
cells (33).  Since then, RNA interference (RNAi) has revolutionized and accelerated our 
knowledge of the role of many genes.  RNAi methods allow straight forward „gene function‟ or 
„loss of function‟ studies. The RNA-dependent gene silencing process (RNAi) is initiated by 
short double-stranded (dsRNA) molecules (53). When these dsRNA molecules are introduced 
ectopically into cells or are endogenously generated, they are processed by Dicer, a type III 
RNase endonuclease (19).  The enzyme mediates dsRNA cleavage and produces small fragments 
of 21-13 nucleotides in length called small interfering RNA ( siRNA‟s) (19).  These siRNA‟s are 
loaded into the RNA-induced silencing complex (RISC) which is the effector in the gene 
silencing process (89). The siRNA duplex unwinds and couples to RISC.  The single stranded 
siRNA in RISC guides the sequence specific binding to the target mRNA‟s which is then cleaved 
leading  to its degradation (89). 
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 RNAi screens in Drosophila cells 
Our knowledge of host-pathogen interaction is limited for obligate intracellular bacteria.  
In particular, host factors needed for replication are not very well known. This knowledge gap is 
largely due to our inability to manipulate mammalian cells effectively and because of the lack of 
genetic tools.  However, as outlined above, Drosophila is used as a model system to address 
host-pathogen interactions.  Drosophila offers several advantages for these studies.  Drosophila 
cell lines are available and grow at atmospheric CO2 concentrations (48, 91).  The two most 
commonly used Drosophila cell lines used are Schneider line 2 (S2) and Kc 2 (91).  The S2 and 
Kc 2 cell lines were derived from primary cultures of D. melanogaster embryonic cells that 
spontaneously immortalized in vivo (49, 122).  Interestingly, these cells had hemocyte-like 
properties such as the ability to adhere to foreign surfaces and to phagocytize a variety of targets 
(113).  Moreover, S2 cells also possess functional toll and immunodeficiency pathways that 
regulate inflammatory responses such as inducible antimicrobial peptide expression (125).  This 
allows for the manipulation of transduction cascades which share striking similarities to the 
mammalian immune response.  These hemocytes-like cells provide  insect equivalents to the 
mammalian macrophages and allowed the study of  pathogens that infect macrophages (18).  
Additionally, long dsRNA‟s are easily taken up by Drosophila cells and a bathing protocol can 
be used without the use of any transfection reagent (33).  Therefore, it is easy to knock-down a 
gene of interest in these cells allowing loss of function studies (33).  Recently, the availability of 
genome-wide dsRNA library at the Drosophila RNAi screening center (DRSC) added another 
advantage to the utility of the system, facilitating a high throughput platform to analyze gene 
functions systematically (23, 56).  
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Several RNAi screens using Drosophila cells have been used to study host-pathogen 
interactions (9, 10, 29, 38, 41, 105-108, 113, 124).  In such screens, hemocyte-like S2 or Kc cells 
were grown in 96-or 384-well formats and were treated with  a library or sub library of double 
stranded RNA‟s that carry out highly specific RNAi mediated knockdown of each of the 
Drosophila mRNA‟s (111).  These cells were then assayed for bacterial entry, survival or 
replication using different read outs such as such as fluorescence, cell level imaging, sub-cellular 
imaging or luminescence (111).  These screens have identified distinct host genes that are 
essential in establishing the infection by various pathogens with overlapping or redundant 
specificities.  The results from these screens have helped in identifying many different classes of 
entry receptors that are involved in the uptake of broad range of bacteria.  These receptors 
included PGRP‟s (113), SR-C1(113), Eater (69), Nimrod (71) and the class B scavenger receptor 
Peste (9).  Some screens have also revealed intracellular components and other downstream 
process in a variety of pathogens.  These include genes required for actin remodeling (Arp 2/3 
complex), vesicular transport genes such as COPI and COP II complex, genes required for 
vesicular trafficking between ER and golgi and genes required for docking the plasma membrane 
for exocytosis (9, 29, 71, 113, 124).  Altogether, these observations suggest that each microbe 
subverts a unique cellular compartment to complete its replication.  For example, Legionella 
pneumophila prevent phagosome lysosome fusion and require the ESCRT (endosomal sorting 
complex required for transport) machinery to alter the phagosome environment.  Francisella 
tularensis escape from phagosomes requires a type III P14 kinase, PI4CA, a ubiquitin-specific 
peptidase, USP22 and E3 ubiquitin ligase, CDC27 to replicate within the cytoplasm (10, 20, 
120). 
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 Limitations and future prospects of cell based RNAi screens in Drosophila 
In the past few years, RNAi screens in Drosophila cells provided insights about bacterial 
intracellular replication.  After candidate genes are identified in Drosophila, the next step is the 
screening of homologs in human cell lines to provide a better understanding of mammalian 
systems.  Additional gene validations can also be done in adult flies using a genome-wide library 
of transgenic flies (39).  The library consist of upstream activating sequence (UAS)-driven 
inverted repeats specific for  most genes which cause gene inactivation in vivo (39). Although, 
RNAi screens allow us to test the function of all genes in a given genome in a rapid, systematic 
and unbiased manner,  it is also important to highlight that “off target effects” can occur and are 
the major drawback of the technique (22, 70).  Off target effects cause degradation of non 
specific mRNA and subsequently leads to false positive reads (70).   However, improving RNAi 
libraries and revalidation of candidate genes is the best solution to eliminate false positive reads. 
 
 In vivo RNAi in Drosophila 
 As a complement to cell-based RNAi screening methods, it is also possible to silence 
host genes required to combat infection in intact flies.  This technology gives us more 
information about the complex biology of the whole organism.  RNAi is cell autonomous in D. 
melanogaster (118, 128) unlike C. elegans where RNAi-induced gene silencing is systemic (97).  
Although this property makes it more difficult to silence genes, it does allow for tissue-specific 
gene silencing.  This spatial and temporal control of gene expression by UAS/ GAL4 system has 
only been possible after the landmark discovery  by Brand and Perrimon (24). 
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The Gal 4 gene encodes for a yeast, Saccharomyces cerevisiae, transcriptional activation 
protein which is 881 amino acids long.  It controls the gene required for galactose metabolism. 
The upstream activating sequence (UAS) is the promoter where GAL4 binds (63, 73, 74).  Since 
eukaryotic transcription machinery is highly conserved, this system can also be used in other 
species.  Expression of GAL4 activates reporter genes in Drosophila without any deleterious 
effects (43, 54).   Specific gene transcription is done by crossing transgenic flies that carry genes 
under the control of UAS with transgenic flies that make GAL4 (24).  
  
 
Figure 1.1  Mechanism of transgenic RNAi in Drosophila using the GAL4/UAS expression 
system.  Adapted from  (7) 
           
The mechanism relies on the GAL4/UAS system to control the expression of a transgene 
cloned into a vector as inverted repeats.  In the progeny, the transgene produces a double-
stranded RNA (dsRNA) that forms a hairpin structure, which then triggers a RNAi response 
(Figure 1.1)  (88).  The dsRNA is cleaved by the ribonuclease enzyme Dicer (67).  Drosophila 
has two paralogs of Dicer, dcr-1 and dcr-2 (67).  Cleavage of dsRNA by Dicer leads to 
formation of 21- to 23-nt siRNA (67).  The siRNA is then loaded into the multiprotein RISC 
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complex where the siRNA duplex unwinds (67).  Active RISC complex loaded with guide strand 
then leads to sequence specific degradation of target mRNA (67).   This process allows for high 
specificity in gene targeting.   
 
            These RNAi lines were constructed by cloning short gene fragments (300-400bp) as 
inverted repeats (IRs).  First generation vectors used constructs inserted into the genome at 
random sites using P element transformation (99, 104) .   However,  this technique had positional 
effects and  generated false negatives (98).  This problem was solved by the second generation 
vector which was called the VALIUM series of vectors.  To achieve high integration specificity, 
a phage, PhiC31, targeted integration method was used (62, 104).  This technique permitted 
integration at sites in the genome that showed optimal expression and optimal RNAi effects were 
observed (104).  These RNAi lines are available from the Vienna Drosophila RNAi collection 
(VDRC) (39).  This library has 15,072 RNAi fly lines targeting 13,327 genes (39, 96).   The 
Transgenic RNAi project (TRIP) collection targets 3,024 genes available (96, 98).  These RNAi 
fly lines, allow genome wide RNAi screens to systematically analyze gene functions in the intact 
fly.  This method also reduces “off target effects” which is a major problem with  cell based 
RNAi screens (104). Moreover, with more transgenic fly lines availability, it is possible to 
confirm data with a second independent transgenic line. 
 
             Recently, a genome-wide in vivo RNAi screen identified several Drosophila genes that 
conferred resistance to the Gram-negative bacterium, Serratia marcescens (34).  Cronin et al. 
used 13,053 RNAi transgenic fly lines.  This represented 78% of Drosophila genome (34).  Their 
initial screen identified susceptible and resistant candidates using ubiquitous (whole organism 
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expression) RNAi gene silencing. This was followed by the two cell type specific screens where 
genes were specifically silenced in the gut epithelium and in hemocytes (34).  They identified 
genes involved in intracellular processes, stress response endocytosis, and exocytosis as essential 
for the bacteria replication in the gut.  Genes linked to phagocytosis, vesicle trafficking and 
stress responses were required in the hemocytes for infection.  The JAK-STAT pathway was also 
identified as an essential host defense process in the gut (34)   
 
           In vivo, RNAi screening has not only contributed to a better understanding of  host-
pathogen interaction, but has also facilitated a better understanding of  other relevant fields of 
biology such as notch signaling (34, 93, 119)  heart function (94), muscle development (123) and 
obesity (109).  Therefore, in vivo and in vitro RNAi screens in Drosophila have provided 
powerful means for biologists to characterize gene functions.   
Ehrlichia chaffeensis 
 Classification 
 Ehrlichia chaffeensis is classified under the phylum: proteobacteria, order: Rickettsiales 
and family: Anaplasmataceae (46, 58, 114).  Rickettsiaceae and Anaplasmataceae are two 
families in the order Rickettsiales (46).  Under the family Anaplasmataceae, four genera have 
been classified namely, Anaplasama, Ehrlichia, Wolbachia and Neorickettsia (46).  Four 
organisms have been confirmed to be human pathogens in the family Anaplasmataceae: 
Ehrlichia chaffeensis, Anaplasma phagocytophilum, Neoricketttsia sennetsu and Ehrlichia 
ewingii (42).   These bacteria are  the causative agents of human monocytic ehrlichosis (HME) 
(11)), human granulocytic anaplasmosis (28), grandular fever (26) and granulocytic ehrlichosis 
(90) respectively.  Recently, a new Ehrlichia species, Ehrlichia Wisconsin a close relative of E. 
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muris (98% sequence homology), was reported (110).  However, because there are only a few 
isolates and there is limited genetic data, the exact taxonomic placement has not been determined 
(110). 
       
 
 Human Monocytic Ehrlichosis and Transmission of the disease  
Ehrlichosis is a tick-borne zoonotic disease caused by a Gram-negative, obligatory 
intracytoplasmic bacterium, E chaffeensis.  The first case of human monocytic Ehrlichosis was 
reported in 1986 in a man bitten by ticks in northern Arkansas (50, 102).  The bacterium lacks 
capsules or pili and bind to host cells via the outer membrane (115).  After 7- 10 days of 
infection, inclusions called morula are seen in the cytoplasm of mononuclear cells (117).  E. 
chaffeensis is primarily vectored by Amblyomma americanum (lone star tick) (12).  An important 
natural reservoir of E. chaffeensis in the USA is white tail deer (Odocoileus virginianus) (37, 
81).  This organism is transmitted transtadially in ticks (103).  Several other vertebrates may also 
act as reservoirs including domestic dog (133), domestic goat (45), white footed mouse (85), red 
fox (36), raccoon (44) and coyote (68).  The bacterium enters vertebrate blood via a bite from an 
infected tick.  A. americanum has a three-host life cycle and to transform from one stage to the 
other (larvae – nymph– adult) the molting process in ticks requires a vertebrate blood meal (103).  
Thus, humans become hosts when ticks bite them accidently. 
. 
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 Clinical Symptoms 
Although HME is one of the diseases reported by the U.S. Centers for Disease Control 
and Prevention (CDC), it is probably under reported because of its common symptoms.  Within 
1-2 weeks infected persons show symptoms of malaise, back pain or gastrointestinal symptoms 
(51, 55).   Early symptoms are “flu” like (46).   During the course of infection, other symptoms 
observed are lymphadenopathy, diarrhea, vomiting and abdominal pain (51, 55, 57).  About 30-
40 % of patients develop a rash in the later course of disease and severe illness is more frequent 
in immunocompromised individuals (101, 102).  Untreated cases may progress to death which 
may occur as early as the second week of illness (87).  Therefore, the disease manifests as a 
moderate-to-severe disease.  Tetracycline/doxycycline is used as a choice of drug.  Most patients 
become afebrile within 1 to 3 days following treatment (46, 101).  These drugs reversibly bind to 
the 30s ribosomal subunit and prevent the formation of peptide chains and thus inhibit bacterial 
protein synthesis.  There is little or no evidence for alternative antibiotic treatments as in vitro β 
lactams, cephalosporins, macrolides and aminoglycosides are inactive against E.chaffeensis 
(126).   
 
 Geographic Distribution 
The prevalence of ehrlichiosis largely depends on the distribution of tick vectors and 
reservoir mammalian works (101).  A. americanum is prevalent in midwestern, south-central and 
southeastern United States (47).  Most cases that have been reported to the U.S. Centers  for 
disease control and prevention (CDC) are from the States of Missouri, Oklahoma, Tennessee, 
Arkansas and Maryland (100, 126).  Ehrlichiosis occurs worldwide and has also been recently 
reported in China (130), Korea (64), Mali (127) and Peru  (31, 84, 92, 127, 130) . 
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 Host Response to E. chaffeensis infection and immunology  
E. chaffeensis is unique in its strategy to subvert host immune responses.  Our knowledge 
of immune mechanisms following E. chaffeensis infection in humans is based mainly on work in 
rodents.  Various inbred mouse strains have been used to study the role of cellular and humoral 
immunity (59, 61, 131).  Wild-type mouse strains clear the bacterium within 16 days while 
infection persists for  one to several months in mice that are defective in macrophage and T-cell 
functions (61).  Mice lacking functional toll-like receptors 4 (tlr4) alleles delay bacterial 
clearance for approximately two weeks as compared to wild-type mice (61).  Tlr 4 mutant mice 
produce decreased levels of nitric oxide and interlukin-6 (IL-6) demonstrating the importance of 
macrophage stimulation in the clearance of E chaffeensis (60). Although, E. chaffeensis lack the 
ability to synthesize LPS, it may be possible that other molecular patters found on E. chaffeensis 
interact with Tlr4 (21, 27).  In contrast, Tlr4 mutant mice appear normal when infected with  
A.phagocytophilum (21).  However, blood analysis and necropsy revealed clinical signs such as a 
neutropenia, monocytosis, and intracytoplasmic morulae in neutrophils for as long as 20 days 
(21).  This suggests that that lack of Tlr4 function may affect the mice longer than has been 
appreciated (21, 27).   Mice lacking functional major histocompatibility complex class II 
(MHCII) genes are unable to clear E. chaffeensis and showed persistent infection suggesting that 
functional MHCII molecules are essential for clearance of E. chaffeensis (61).  The role of 
CD4
+
T cells and CD8
+
T cells in the pathogenesis of E. chaffeensis has also been investigated 
(65).  The CD4
+ 
T-cell-deﬁcient mice showed increased susceptibility to both high and low doses 
of E. chaffeensis while the CD8
+ 
T-cell-deﬁcient mice were resistant to a low dose but were 
susceptible with a high dose of E. chaffeensis (65).  The absence of CD8
+ 
T cells leads to 
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decrease in TNF-α and IL-10 production, which may be the cause of reduced tissue injury and 
bacterial burden (65).  Based on these observations it is hypothesized that CD8+T cells mediate 
the disregulated overproduction of TNFα in fatal ehrlichosis, to induce toxic shock (65).   In 
contrast, combined immune deficient mice (SCID), that lack both B and T-cell function, develop 
severe fatal disease and become moribund 24 days post infection suggesting that both T and B 
cells are necessary for adaptive immunity during E. chaffeensis infection. (131).  Mice deficient 
for T cells but with intact B cell function become infected but do not become ill (131).  
Moreover, administration of antibodies targeted against the outer membrane protein of E. 
chaffeensis or immune serum from immunocompetent mice in SCID mice result in protection 
from disease  demonstrating  a protective role of antibodies which recognize outer membrane 
proteins of E. chaffeensis and the importance of intact cellular immunity for complete recovery 
(60, 61, 132) 
 
The clinical manifestation of HME is also mediated by other immunological responses 
such as secretion of variety of cytokines.  The cytokine profile in in vitro studies using human 
monocytic cell line (THP-1) that  is infected with E. chaffensis showed induction of IL-1β, IL-8 
and IL-10 while there is no induction of GMCSF, IL-6 and TNFα (75).  The absence of  TNFα 
and IL-6 is unique among known intracellular bacteria which suggests that E. chaffeensis may 
need more stringent inhibition of macrophage activation to survive (75).  However, additional 
proinflammatory cytokines such as IL-6 and TNFα are induced when infected cells were exposed 
to hyperimmune serum containing anti E chaffeensis IgG antibodies (76).  This suggests that 
antibodies against E.chaffeensis can induce the production of proinflammatory cytokine which 
may play important role in pathophysiology of the disease and may be detrimental to the host 
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(76).  Another study categorized changes in gene transcription  during E. chaffeensis infection in 
THP-1 cells (134).   Post infection, a wide range of genes across the host genome are altered.  
After exposure to E. chaffeensis at different time points, transcription of genes involved in 
biosynthesis and metabolism, ion channel transport, signal transduction, cell differentiation and  
membrane trafficking are altered three fold (134).  The authors focused on the genes that are 
down regulated  which are innate immune response, apoptosis and phagosome lysosome fusion 
genes (134).  In particular, E. chaffeensis repressed host-cell cytokine genes: IL-15 and IL-18 
that are known to modulate innate and adaptive immunity to intracellular bacteria.   These genes 
are hypothesized as host genes that E. chaffeensis down regulate for its survival (134).   
 
 
 Known host factors required for Ehrlichial survival and replication 
  Our knowledge about host factors that bacteria utilize during entry, survival and 
replication is nascent.  However, some studies have been initiated (16, 79, 80, 116, 134).  For 
example, cholesterol is needed for Ehrlichia infection.  E.chaffeensis that have been treated with 
Methyl β cyclodextrin, a cholesterol sequesteration and extraction reagent are significantly less 
invasive (79).  It is believed that the cholesterol substitutes for the peptidyl glycan which is not 
present in the bacterial membrane because E. chaffeensis lacks the genes for biosynthesis of 
peptidoglycan (79).  Like many bacteria, iron is critical for E. chaffeensis replication (16).  
Monocytes treated with iron chelators such as deferoxamine, fail to support bacterial replication  
suggesting the dependence of E. chaffeensis on cytoplasmic iron pool (16).  Transferrin may be 
used to scavange iron during replication because exogenously added transferrin is accumulated 
by E. chaffeensis during replication.  This suggests that transferrin  may be used to scavange iron 
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during replication (16).  Although, aforesaid mentioned studies have found some of the critical 
host factors E. chaffeensis require during replication, other host genes utilized by the bacteria for 
its survival and replication are yet to be elucidated. 
 
Recently, our group attempted to identify Drosophila host genes that are required for E. 
chaffeensis infection (82).   The investigators used microarray and mutant screening techniques 
to identify  several  host genes that contribute to E. chaffeensis replication (82).  Experiments in 
mutant flies confirmed five genes that affect the replication of E. chaffeensis in vivo.  The 
functions of the identified genes are diverse and include:  phagocytosis/engulfment (CG6479) 
(2); fatty acid binding/mitotic sister chromatid binding (san) (5);  chitinase activity (CG3044 
(Cht11)) (4);  uridine/cytidine kinase activity (CG6364) (1); and  enoyl –CoA hydratase activity 
(CG6543 ) (3).  Further analysis of gene products of CG6364 suggests that E. chaffeensis 
requires cytosine or cytidine for its replication (82).  Supplementation of cytosine to S2 cells 
culture enhanced Ehrlichia replication (82).  One hypothesis suggested by the investigators is 
that since cytidine is the least abundant nucleoside in cells, its use by the Ehrlichia may be 
stressful on the host cell processes including host cell defense mechanisms.  This would make 
conditions amenable for E. chaffeensis growth (82). 
 
 
 Significance and Conclusion 
Ehrlichosis is an emerging infectious disease (42).  From 2003-2009 a total of 4,352 
cases were reported by CDC with the highest number of cases (944) reported in 2009 (6, 126). 
Most cases of HME are seen in adults and elderly and since the population of United States has 
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become older, the growth of a susceptible human population is another factor contributing to 
emergence (42).  Case fatality rate of HME is 3% with deaths occurring most commonly in 
immunosuppressed individuals (126).  The disease has been reported globally and yet there is no 
vaccine against this emerging infectious disease (31, 90, 130).  The complete understanding of 
the disease‟s pathogenesis requires the understanding of the genetic requirement and the 
intracellular niches within which this bacterium replicates. Therefore, in this current work, 
Drosophila RNAi lines were selected from a pilot microarray screen completed earlier in our 
laboratory (bioinformatics.kumc.edu/mdms/login.php).  My goal was to identify tissues in which 
the bacterium replicates.  In this study, I used the UAS/ GAL4 system to control the expression 
of the target genes in adult flies.  Using this system, I tested if we can knock-down a gene of 
interest in a tissues-specific manner and monitored E. chaffeensis infection in adult flies.  The 
study provides valuable information about the intracellular niches where the bacterium 
replicates.  
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Chapter 2 - Ehrlichia chaffeensis replication in adult  
Drosophila melanogaster 
 
 Abstract 
 Ehrlichia chaffeensis is a Gram-negative, obligatorily intracytoplasmic bacterium and 
the causative agent of a tick-borne disease, human monocytic ehrlichiosis.  In vertebrates, E. 
chaffeensis exhibits tropism for monocytes /macrophages.  However, no clear requirements for 
cell tropism have been defined in ticks.  Previously, our group identified two host genes that 
control E. chaffeensis replication in vivo in Drosophila.  We used these two genes, CG6364 and 
separation anxiety (san) to test the hypothesis that E. chaffeensis replicates in arthropod 
hemocytes.  Using the UAS/GAL4 RNAi system, we generated F1 flies (RNAi flies) and 
confirmed ubiquitous-or tissue-specific reduction in the transcript levels of the targeted genes.  
When RNAi flies were screened for Ehrlichia infections, we found that when either CG6364 or 
san were specifically suppressed in the hemocytes or in the fat body E. chaffeensis failed to 
replicate or cause infection.   Deletion of these genes in the eyes, wings or the salivary glands did 
not impact fly susceptibility or bacterial replication within these organs.  Our data demonstrate 
that in Drosophila, E. chaffeensis replicates within the hemocytes, the insect homolog of 
mammalian macrophages, and in the fat body, the liver homolog of mammals.  This study 
provides insights about replication sites of E. chaffeensis in arthropods.    
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 Introduction 
E. chaffeensis is a an obligate,  intracellular bacterium and is the causative agent of 
human monocytic ehrlichiosis (HME) (4).   The disease is usually more severe or fatal  in 
immunosuppressed individuals (14).  HME has been reported globally and yet there is no 
vaccine against this emerging infectious disease (23, 25, 36, 39, 40).   E. chaffeensis is 
transmitted primarily by Amblyomma americanum (lone star) ticks.  In vertebrates, it has tropism 
for monocytes/macrophages (26).   However, the tissue tropism of E. chaffeensis in ticks has 
remained obscure.  
         
To determine where E. chaffeensis replicates in arthropods, we used D. melanogaster.  
Drosophila have been successfully used to study a wide variety of host-pathogen interactions  
including the intracellular pathogens Listeria monocytogenes (24) , Mycobacterium marinum 
(12) , Francisella tularensis (38) and  Plasmodium gallinaceum (32).  Previously, our group 
demonstrated that E. chaffeensis is capable of infecting and completing its life cycle and 
maintaining infection in both S2 cells and adult flies (21, 22).  Two genes, CG6364 (1) and san 
(2) , were found to control bacterial replication as judged from a  microarray screen analysis  and 
follow-up challenge experiments with mutant flies (20).    We used tissue-specific gene knock-
out techniques to investigate the tissue tropism of E. chaffeensis. Specifically, CG6364 and  san 
were silenced using the GAL 4 (15)  transcription factor and the UAS promoter (10).  This tool 
allowed us to inactivate the genes of interest ubiquitously or in specific tissues in adult flies to 
screen for bacterial replication. The working hypothesis is that in Drosophila, E. chaffeensis 
replicate in hemocytes, the insect equivalent of macrophages.  Results pointed in the thesis will 
support the working hypothesis that Ehrlichia replicate within the hemocytes and the fat body of 
adult D. melanogaster. 
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 Materials and methods 
Cell lines and E. chaffeensis infections.  
 E. chaffeensis (Arkansas isolate) was propagated in DH82 cells (ATTC # CRL-10389, 
American Type Culture collection, Rockville, Md.), a dog macrophage cell line.  The DH82 cells 
were grown in Eagle's minimal essential medium (EMEM) supplemented with 3.5% fetal bovine 
serum, 3.5 % Nu serum and 2 mM L-glutamine.  Cells were grown at 37°C in 8% CO2 – 92% air 
atmosphere.  Infectivity was determined by examining cyto-centrifuged cells stained with Dif-
Quik stain (Fisher Scientific Company, Kalamazoo, MI; # 122-929).  When more than 80% of 
cells were infected, the cells were removed with a cell scraper and frozen at -80°C in cryogenic 
vials.  Bacteria numbers were quantified using a TaqMan-based quantitative reverse transcriptase 
PCR (qRT-PCR) assay as described below.  Purification of host cell-free bacteria was carried out 
as follows.  Cells were scraped from tissue culture dishes.  The recovered infected cells were 
placed in a 50-ml, sterile centrifuge tube and shaken with glass beads.  The preparation was 
centrifuged at 600 x g for 20 minutes.  The supernatant with host cell-free bacteria was 
transferred into a sterile tube and centrifuged at 15,000 x g for 20 minutes.  The bacterial pellet 
was resuspended in sterile phosphate-buffered saline (PBS) mixed with blue food dye at a ratio 
of 0.6 ml dye for every 1 ml of PBS to help us visualize appropriate fly injection.  Most flies 
were injected with 6,000 bacteria per fly; however, some early experiments were done with 
1,500 bacteria per fly. 
 D. melanogaster  
D. melanogaster flies were raised on standard dextrose/molasses/yeast medium at 18-
29°C.  The following fly lines were used: yellow white (yw) and arm-Gal4, hml ∆Gal4, YP1-
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Gal4, MS1096, Gmr-Gal4, Fhk-gal4, UAS-6364 and UAS-San.  The yw fly line was maintained 
at Kansas State University.  The arm-Gal, fly line (31) was received as a gift from Joan Hooper 
(University of Colorado, Anchutz Medical campus, Denver CO). The Fhk-gal4 and YP1-Gal4 
was received as a gift from Tony Ip (The University of Massachusetts Medical School, 
Worcester MA).  The Hml ∆Gal4 fly line was received as a gift from Michael Galko (MD 
Anderson Cancer Center, Houston TX).  The MS1096 and Gmr-Gal4 fly lines were obtained 
from the Bloomington Drosophila Stock Center at Indiana University, Bloomington, IN.  UAS-
dsRNA transgenic lines were obtained from the Vienna Drosophila RNAi Center (VDRC) (10).   
5-7 virgin females carrying the Gal4 promoter were crossed with 3-4 males carrying 
different UAS-dsRNA transgenes to generate F1 flies that had tissue-specific or ubiquitous 
deletion of CG6364 and san genes. 
 RNA extraction. 
The TriReagent (Molecular Research Center) RNA extraction method, as was previously 
described by our group (22), was used to extract RNA from flies or host cell-free bacteria.  
Bacterial pellets or fly homogenates were resuspended in 1 ml of TriReagent.   Preparations were 
transferred to 2.0 ml, Heavy Phase Lock Gel tubes (5 Prime/Eppendorf, Westbury, New York; 
#2302830).  Three hundred microliters (300 μl) of chloroform was added and the mixture was 
vortexed for 15 seconds.  The samples were centrifuged at 12,000 x g for 10 minutes at 4°C and 
the aqueous phase was transferred to clean 1.5 ml tubes.  Five hundred microliters (500 μl) of 
isopropanol was added and RNA was precipitated at -20°C for 24 hours.  Samples were 
subsequently centrifuged at 12,000 x g for 10 minutes at 4°C.  The RNA pellet was washed with 
1 ml of 70% ethanol and samples were centrifuged at 7.400 x g for 5 minutes at 4°C.  The 70% 
ethanol was decanted from the pellet and residual ethanol was allowed to evaporate for 5 
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minutes.  RNA was resuspended in 50 μl of nuclease-free water.  RNA concentrations were 
determined spectrophotometrically (NanoDrop Technologies, Wilmington, DE).  
 Quantification of bacterial numbers for infection/injection and in infected flies. 
RNA from host cell-free Ehrlichia was extracted as described above.  A TaqMan-based
 
real-time reverse transcriptase PCR (RT-PCR) was used to quantify bacterial numbers (34).  One 
hundred fifty-one thousand nano gram of RNA were used for each reaction.  Real time 
quantitative RT-PCR (qRTPCR) was performed using the Invitrogen‟s One-Step Platinum qRT-
PCR kit (#11732) in a Cepheid Smart Cycler (Cepheid,Sunnyvale,CA).  E .chaffeensis RNA was 
detected using primers specific for the 16S ribosomal RNA gene (NCBI Accession # M73222).   
Custom synthesized primers and probes were obtained from Integrated DNA Technologies 
(Coralville, IA) and were used.  The sequence of the primers used were; forward primer, RRG3 
(5‟ CAATTGCTTATAACCTTTTGGTTATAAAT 3‟) and reverse primer, RRG27 (5‟ 
GTATTACCGCGGCTGCTGGCAC 3‟).  Serial 10-fold dilutions of the RNA from infected 
DH82 cells were used to generate standard curves plotting log number of bacteria versus the 
corresponding Ct value.  The cycling condition used for the assay were: 48°C for 30 minutes, 
94°C for 4 minutes, then 35 cycles of 94°C for 30 seconds, 52°C for 30 seconds, and 72°C for 1 
minute. 
To quantify  bacterial numbers in injected/infected flies, anesthetized flies were 
transferred to 1.5 ml tubes (Kimble Kontes #749510-1500), and crushed with disposable pestles 
in 1 ml of TriReagent  as previously described (20).  Bacteria numbers were estimated from 
RNA samples using quantitative RT-PCR (qRT-PCR) as described above.  Drosophila ribosomal 
protein 15a (NCBI Accession #NM_136772) gene was used as used as housekeeping.  The 
sequence of the primers used were: forward primer (5‟ TGGACCACGAGGAGGCTAGG 3‟) 
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and reverse primer (5‟ GTTGGTGCATGGTCGGTGA 3‟) and Taqman probe 
(TGGGAGGCAAAATTCTCGGCTTC).  The cycling condition used for the assay were: 48°C 
for 45 minutes, 94°C for 2 minutes, and then 35 cycles of 94°C for 45 seconds, 50°C for 1 
minute, and 72°C for 1.5 minutes. 
 Estimation of silencing efficiency. 
To quantify the level of transcriptional silencing in RNAi flies, whole-flies or specific fly 
tissues were used to probe for specific transcript levels.  Fly-tissues were transferred to 1.5 ml 
tubes and crushed with disposable pestles in 1 ml of TriReagent for RNA extraction.  Transcript 
levels of the gene of interest in F1 flies, were assessed in the following whole-flies: ubiquitous 
(UAS San X arm-Gal4 or UAS-CG6364 X arm-gal4);  hemocytes (UAS San X hml-Gal4 or 
UAS-CG6364 X hml-gal4); fat body (UAS-San X YP1-Gal4 or UAS-CG6364 X YP1-Gal4).  For 
wing-specific and eye-specific knock-down, fly heads or wings were used.  For  body-specific 
and salivary gland-specific knock-down, fat body or salivary glands dissected from wandering 
third-instar larvae were used.   RNA from homogenates were extracted as described above.   
Transcript levels were determined in RNA samples using qRT-PCR using the Invitrogen‟s 
Superscript III Platinum SYBR Green One-Step qRT-PCR kit in.  Primers were obtained from 
Integrated DNA Technologies (Coralville, IA).  Drosophila ribosomal protein 15a was used as 
used as housekeeping.  Drosophila CG6364 (NCBI Accession #NM_142984) was detected using 
forward primer (5‟TGTCCATCAGTCAGGACAGC 3‟) and reverse primer 
(5‟CTCCACTTTGTGGCCCTTTA 3‟). The cycling condition used for the assay were: 48°C for 
30 minutes, 95°C for 3 minutes, and then 45 cycles of 95°C for 15 seconds, 56°C for 30 seconds, 
and 60°C for 1 minute.  Drosophila San (NCBI Accession # NM_080040) was detected using 
forward primer (5‟ACCCGAACAATCAGGAACAG 3‟) and reverse primer 
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(5‟ACCCGAACAATCAGGAACAG 3‟).  The cycling condition used for the assay were: 48°C 
for 30 minutes, 95°C for 3 minutes, and then 45 cycles of 95°C for 15 seconds, 50°C for 30 
seconds, and 60°C for 1 minute. 
To calculate knock down efficiency serial 10-fold dilutions of RNA and corresponding Ct 
values were used to plot standard curves (mean of three experiments).  Primer efficiency was 
calculated using the following equation (29): 
Efficiency = 10
(-1/slope of standard curve).
 
 Primer efficiency values were used to calculate the relative change in gene expression by 
the following equation (29): 
 
 
                         (Efficiency of gene interest 
Gene interest:ΔCt control – treated
) 
                     (Efficiency of housekeeping gene 
Housekeeping gene:ΔCt control – treated
) 
 
 
Parental lines (UAS and Gal4 constructs) and yellow white (yw) flies served as normal 
controls and were set at 100 % expression for the gene of interest.  Relative level of gene 
expression in RNAi flies as compared to controls was calculated to estimate the knock down 
efficiency. 
Infections.   
Adult flies were used to assess the effect of gene knockdown on E. chaffeensis infections. 
Male and female flies were anesthetized on a CO2  anesthesia  pad (Genesee Scientific, San 
Diego, model# 59-119). Flies were injected in the thorax with 50.6 nl of sterile PBS-blue food 
dye solution (38% v/v) or ehrlichia resuspended in PBS-blue food dye solution (38% v/v).   
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Injections were made in the abdomen of the fly with pulled glass capillary needles using a 
Nanoject II (Drummond Scientific Company, Broomall, PA).  Following injection, flies were 
maintained in clean bottles with molasses/yeast caps.  Survival was monitored daily for 4 days.  
 Statistics.   
Survival data were analyzed for significance using the log-rank test of Kaplan Meier 
plots using Prism Graphpad software (La Jolla, CA).  Data are presented as the mean
 
± standard 
error (SE) of independent experiments.  P values of <0.05 were
 
considered highly significant.   
Bacterial numbers were analyzed by using the StatMost Statistical Package (Data XIOM, Los 
Angeles, CA, USA).  Data are presented as the mean
 
± standard error (SD) of independent 
experiments.  Statistical values were determined using the student‟s t-test (two-tailed, general).  
 Results 
CG6364 and San are required for in vivo E. chaffeensis replication in adult D. 
melanogaster 
E. chaffeensis is capable of infecting and completing its life cycle in S2 cells and adult 
flies (21, 22).  By performing microarrays on S2 cells and screening mutant adult flies,  previous 
work identified  two host genes, CG6364 (1) and san (2)  that control the replication of Ehrlichia 
in vivo (10).  In vertebrates, E. chaffeensis exhibits tropism for monocytes/macrophages (26).   
However, no clear requirements for cell or tissue tropism have been defined in ticks.  To screen 
for arthropod tissues in which E. chaffeensis replicates, we employed whole-organism in-vivo 
RNAi to do tissue specific inactivation of CG6364 (1)  or san (2).   We took advantage of a fly 
collection that consists of RNAi transgenes, and expressed through the binary UAS-GAL4 system 
(5, 10).   The availability of diverse set of  GAL4 fly lines allowed  us to silence genes in  a tissue 
specific manner to determine where E. chaffeensis replicate in arthropods (15).   
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To determine whether CG6364 and San could be efficiently silenced using the UAS-
GAL4 system, we individually crossed transgenic flies carrying inverted repeats of the CG6364 
gene under the control of UAS to flies carrying armadillo (arm)-Gal4 (ubiquitous Gal4 
insertions) to silence CG6364 ubiquitously, in the F1 progeny.  Using qRT-PCR, we confirmed 
transcript reduction of CG6364 in the RNAi flies in comparison to wild-type, yw flies and 
parental lines (Table 2.1).  After confirming an RNAi silencing effect on CG6364, flies were 
experimentally challenged with E. chaffeensis.  E. chaffeensis bacteria were injected into the 
abdomen of wild-type, parental lines and CG6364-RNAi flies.  We observed that there was 
approximately 48% death in wild-type and parental lines after 96 h in comparison to control flies 
injected with PBS (Figure 2.1; panel A) (P<0.05, log rank test).  However, flies which had 
ubiquitous CG6364-RNAi displayed 85% survival which was significantly better than the wild-
type and parental lines, (Figure 2.1; panel A), (P<0.05, log-rank test).   When we assessed the 
ubiquitous CG6364-RNAi flies for infection we found that E. chaffeensis was cleared from the 
RNAi flies significantly better than wild-type and parental lines after 96 h (Figure 2.2; panel A) 
(P<0.05, t-test).  These experiments confirmed that UAS/GAL4 could be used to efficiently 
silence CG6364 in adult flies and that E. chaffeensis infection in flies was dependent on a 
functional CG6364 gene (20). 
 
Previous studies from our group demonstrated that the gene san was necessary for E. 
chaffeensis infection in D. melanogaster (20).  Therefore, we also silenced san in RNAi  
transgenic flies.  We measured an average of 83 ± 5% reduction of san transcript levels in F1 
RNAi flies (Table 2.1).  When flies were challenged with E. chaffensis san-RNAi flies had 
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approximately 80% survival compared to yw and parental control flies (Figure 2.1; panel B) 
(P<0.05, log-rank test).  Assessment of E. chaffeensis numbers in san-RNAi flies also showed 
98% fewer bacteria in the F1 flies 96 h after experimental challenge (Figure 2.2; panel B)  
(P<0.05, t-test).    
 
 E. chaffeensis replication in adult D. melanogaster 
Ubiquitous tissue silencing of CG6364 and san impeded E. chaffeensis infection in adult 
D. melanogaster.  Therefore, we screened an array of tissues for their ability to support bacterial 
replication.  In vertebrates, E. chaffeensis exhibits a tropism for monocytes and macrophages 
(26).   Therefore, we hypothesized that E. chaffeensis replicates in hemocytes, the insect 
equivalent to mammalian macrophages.  To test this hypothesis, we silenced CG6364 and san in 
the eyes, wings, hemocytes, fat body and salivary glands in a tissue-specific manner in adult 
flies.  We used a eye-specific (Gmr-Gal4), wing-specific (MS1096-Gal4), hemocyte-specific 
(Hml-Gal4), fat body-specific (YP1-Gal) or salivary gland specific (Fhk-Gal4) Gal4 constructs 
to generate F1 flies.    
 
To confirm the tissue specific knock-down of targeted genes, we dissected whole-heads 
and wings to assess eye-specific and wing-specific adult knockdown.   We observed an average 
of 88  ± 2% and 74 ± 15% reduction in transcript levels of CG6364 and san respectively in 
whole heads of F1 transgenic flies generated using eye-specific Gal4 construct in comparison to 
organs from wild-type and parental flies (Table 2.3).   Similarly, we observed an average of 76 ± 
9% and 82 ± 5% reduction in transcript levels of CG6364 and san in the wings of F1 transgenic 
flies generated using wing-specific Gal4 construct in comparison to experimental controls (Table 
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2.2).  To analyze off-target RNAi silencing, we analyzed changes in transcript levels of targeted 
genes in fly-bodies without wings or whole-heads of F1 transgenic flies.  These tissues showed 
negligible changes in transcript levels in comparison to wild-type and parental flies (Table 2.2, 
2.3).  This confirmed the tissue-specific targeting of genes.   
 
Due to the difficulty associated with isolation of hemocytes from adult flies we used 
whole-flies to assess hemocyte-specific knockdown.   RNA levels were reduced by an average of 
79 ± 6% and 62 ± 4 % in hemocyte-specific CG6364 and san-RNAi whole-flies, respectively, in 
comparison to experimental controls (Table 2.1).  Fat bodies and salivary glands are difficult to 
dissect from adult flies.  Since the RNAi effect is applicable at all stage of the Drosophila 
lifespan (10), we isolated the fat bodies and salivary glands from 3
rd
 instar larvae to assess the 
silencing efficiency in the fat body and salivary glands of our RNAi flies.  There was an average 
of 77 ± 8% and 66 ± 12% reduction in transcript levels in the dissected fat body from fat body-
specific CG6364 and san-RNAi third instar larvae, respectively, in comparison to dissected fat 
body from third instar control larvae (Table 2.4).   Similarly, transcript levels in dissected 
salivary glands from salivary gland-specific CG6364 and san-RNAi third instar larvae showed 
that RNA levels were reduced  an average of 95 ± 2% and 90 ± 6%, respectively, in comparison 
to dissected salivary gland from control larvae (Table 2.5).  However, negligible changes were 
observed in CG6364 and san gene expression in RNA samples isolated from third instar larvae 
non salivary gland tissue (Table 2.5).   
 
After confirming a tissue-specific RNAi silencing effect of CG6364 and san, control and 
RNAi flies were experimentally challenged with E. chaffeensis.  We observed that eye-specific 
and wing-specific knock-down of CG6364 and san did not impact fly survival.  RNAi flies were 
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as susceptible to E. chaffeensis infection similar to the wild-type and parental controls (Figure 
2.3; panel A and panel B) (Figure 2.5; panel A and panel B) (P>0.05, log-rank test).  Similarly, 
salivary-gland specific CG6364 and san-RNAi flies were also as sensitive to E. chaffeensis 
infection as control flies (Figure 2.11; panel A and panel B) (P>0.05, log-rank test).   However, 
hemocyte and fat body-specific CG6364 and san-RNAi flies survived significantly better than 
the control flies after infection with Ehrlichia (Figure 2.7; panel A and panel B) (Figure 2.9; 
panel A and panel B) (P<0.05, log-rank test).  Ninty six hours (96 h) after infection, 80 % of 
hemocyte-specific CG6364-RNAi and 85% of hemocyte-specific San-RNAi flies survived in 
comparison to an average of 50 % of yw and parental control flies.  Similarly, after 96 h after 
infection 80% of fat body-specific CG6364-RNAi and 80% of fat body-specific specific San-
RNAi flies survived in comparison to an average of 50% of yw and parental control flies.   
 
 There was no difference in bacterial replication in eye-specific, wing-specific and salivary 
gland-specific CG6364 and san F1-RNAi flies comparison to control flies (Figure 2.4, panel A 
and panel B) (Figure 2.6; panel A and panel B) (Figure 2.12; panel A and panel B) (P>0.05, t-
test).   However, F1 RNAi flies with hemocyte-specific knock-down of CG6364 or san had 
significantly fewer bacteria (Figure 2.8; panel A and panel B) (P<0.05, t-test).  At 96 h time 
point, there were 98% and 95 % fewer bacteria in hemocyte-specific CG6364 or san-RNAi flies 
respectively in comparison to controls (Figure 2.8; panel A and panel B).  Similarly, there were 
97% fewer bacteria in fat body-specific CG6364 or san- F1 RNAi flies (Figure 2.10; panel A and 
panel B).   These data confirm that CG6364 and san are needed for E. chaffeensis replication and 
support the hypothesis that the bacteria replicate in the hemocytes or the fat body in adult 
D.melanogaster. 
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Figure 2.1 Impact of ubiquitous expression of CG6364 (A) or san (B) hairpin RNA on E. chaffeensis 
(EC) infection.  Ubiquitous knock-down of CG6364 and San was accomplished using UAS and Gal4 
constructs as described in materials and methods.  Flies were injected with PBS or cell-free E. 
chaffeensis.  Data presented represent the mean ± SEM of 3-4 independent experiments. 20 flies were 
injected per treatment group per experiment.  The absence of error bars indicates an error smaller than the 
size of the marker.  Statistical significance is represented by * (P<0.05)  
B 
A 
 
A 
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Figure 2.2 Impact of ubiquitous expression of CG6364 (A) or san (B) hairpin RNA on bacterial 
clearance.  Ubiquitous knock-down of CG6364 and San was accomplished using UAS and Gal4 
constructs as described in materials and methods.   Bacterial load was estimated by qRT-PCR for 
Ehrlichial 16S rRNA as described in the materials and methods.  Data presented represent the mean ± SD 
of 2 independent experiments.  Each point represents 4-5 flies per RNA preparation.   The absence of 
error bars indicates an error smaller than the size of the marker.  Statistical significance is represented by 
* (P<0.05)  
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Figure 2.3 Impact of eye-specific expression of CG6364 (A) or san (B) hairpin RNA on E. 
chaffeensis (EC) infection.  Eye-specific knock-down of CG6364 and San was accomplished using UAS 
and Gal4 constructs as described in materials and methods.  Flies were injected with PBS or cell-free E. 
chaffeensis.  Data presented represent the mean ± SEM of 3-4 independent experiments. 20 flies were 
injected per treatment group per experiment.   The absence of error bars indicates an error smaller than 
the size of the marker.  Statistical significance is represented by * (P<0.05)  
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Figure 2.4 Impact of eye-specific expression of CG6364 (A) or san (B) hairpin RNA on bacterial 
clearance.  Eye-specific knock-down of CG6364 and San was accomplished using UAS and Gal4 
constructs as described in materials and methods.   Bacterial load was estimated by qRT-PCR for 
Ehrlichial 16S rRNA as described in the materials and methods.  Data presented represent the mean ± SD 
of 2 independent experiments.  Each point represents 4-5 flies per RNA preparation.  The absence of error 
bars indicates an error smaller than the size of the marker.  Statistical significance is represented by * 
(P<0.05 
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Figure 2.5 Impact of wing-specific expression of CG6364 (A) or san (B) hairpin RNA on E. 
chaffeensis (EC) infection.  Wing-specific knock-down of CG6364 and San was accomplished using 
UAS and Gal4 constructs as described in materials and methods.   Flies were injected with PBS or cell-
free E. chaffeensis.  Data presented represent the mean ± SEM of 3-4 independent experiments.  20 flies 
were injected per treatment group per experiment.  The absence of error bars indicates an error smaller 
than the size of the marker.  Statistical significance is represented by * (P<0.05)  
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Figure 2.6 Impact of wing-specific expression of CG6364 (A) or san (B) hairpin RNA on bacterial 
clearance.  Wing-specific knock-down of CG6364 and San was accomplished using UAS and Gal4 
constructs as described in materials and methods.   Bacterial load was estimated by qRT-PCR for 
Ehrlichial 16S rRNA as described in the materials and methods.  Data presented represent the mean ± SD 
of 2 independent experiments.  Each point represents 4-5 flies per RNA preparation.  The absence of error 
bars indicates an error smaller than the size of the marker.  Statistical significance is represented by * 
(P<0.05)  
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Figure 2.7 Impact of hemocyte-specific expression of CG6364 (A) or san (B) hairpin RNA on E. 
chaffeensis (EC) infection.  Hemocyte-specific knock-down of CG6364 and San was accomplished 
using UAS and Gal4 constructs as described in materials and methods.   Flies were injected with PBS or 
cell-free E. chaffeensis.  Data presented represent the mean ± SEM of 3-4 independent experiments. 20 
flies were injected per treatment group per experiment.  The absence of error bars indicates an error 
smaller than the size of the marker.  Statistical significance is represented by * (P<0.05)  
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Figure 2.8 Impact of hemocyte-specific expression of CG6364 (A) or san (B) hairpin RNA on 
bacterial clearance.  Hemocyte-specific knock-down of CG6364 and San was accomplished using UAS 
and Gal4 constructs as described in materials and methods.   Bacterial load was estimated by qRT-PCR 
for Ehrlichial 16S rRNA as described in the materials and methods.  Data presented represent the mean ± 
SD of 2 independent experiments.  Each point represents 4-5 flies per RNA preparation.  The absence of 
error bars indicates an error smaller than the size of the marker.  Statistical significance is represented by 
* (P<0.05)  
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Figure 2.9 Impact of fat body-specific expression of CG6364 (A) or san (B) hairpin RNA on E. 
chaffeensis (EC) infection.  Fat body-specific knock-down of CG6364 and San was accomplished using 
UAS and Gal4 constructs as described in materials and methods.  Flies were injected with PBS or cell-free 
E. chaffeensis.  Data presented represent the mean ± SEM of 3-4 independent experiments. 20 flies were 
injected per treatment group per experiment.  The absence of error bars indicates an error smaller than the 
size of the marker.  Statistical significance is represented by * (P<0.05)  
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Figure 2.10 Impact of fat body-specific expression of CG6364 (A) or san (B) hairpin RNA on 
bacterial clearance.  Fat body-specific knock-down of CG6364 and San was accomplished using UAS 
and Gal4 constructs as described in materials and methods.   Bacterial load was estimated by qRT-PCR 
for Ehrlichial 16S rRNA as described in the materials and methods.  Data presented represent the mean ± 
SD of 2 independent experiments.  Each point represents 4-5 flies per RNA preparation.  The absence of 
error bars indicates an error smaller than the size of the marker.  Statistical significance is represented by 
* (P<0.05)  
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Figure 2.11 Impact of salivary gland-specific expression of CG6364 (A) or san (B) hairpin RNA on 
E. chaffeensis (EC) infection.  Salivary gland-specific knock-down of CG6364 and San was 
accomplished using UAS and Gal4 constructs as described in materials and methods.    Flies were injected 
with PBS or cell-free E. chaffeensis.  Data presented represent the mean ± SEM of 3-4 independent 
experiments. 20 flies were injected per treatment group per experiment.  The absence of error bars 
indicates an error smaller than the size of the marker.  Statistical significance is represented by * (P<0.05)  
A 
B 
51 
 
 
 
 Figure 2.12 Impact of salivary gland-specific expression of CG6364 (A) or san (B) hairpin RNA on 
bacterial clearance.  Salivary gland-specific knock-down of CG6364 and San was accomplished using 
UAS and Gal4 constructs as described in materials and methods.   Bacterial load was estimated by qRT-
PCR for Ehrlichial 16S rRNA as described in the materials and methods.  Data presented represent the 
mean ± SD of 2 independent experiments.  Each point represents 4-5 flies per RNA preparation.  The 
absence of error bars indicates an error smaller than the size of the marker.  Statistical significance is 
represented by * (P<0.05) 
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Tissues in 
which the 
target gene 
was 
knocked 
down 
 
 
Target 
Gene 
 
% knock-down 
efficiency of 
target gene in 
F1 progeny 
compared to  
wild-type (yw)  
controls 
 
% knockdown 
efficiency of 
target gene in F1  
progeny 
compared to   
UAS construct 
(Parental line 1) 
 
% knockdown 
efficiency of 
target gene in 
F1 progeny 
compared to   
Gal4 construct 
(Parental line 2) 
 
Average % 
knockdown 
efficiency of 
target gene in 
F1 progeny 
compared to 
control flies 
Ubiquitous 
(arm-Gal4) 
CG6364 86 ± 4 90 ± 5 89 ± 9 88 ± 2 
San 86 ± 2 86 ±5 78 ± 4 83 ± 5 
Hemocytes 
(Hml-Gal4) 
CG6364 76 ± 8 85 ± 5 73 ± 3 79 ± 6 
San 61 ± 0 59 ± 2 66 ± 1 62 ± 4 
Fat Body 
(YP1-Gal4) 
CG6364 55 ± 1 26 ± 9 23 ± 1 35 ±18 
San 46 ± 2 28 ± 4 52 ± 3  42 ± 12 
 
Table 2.1 Percent (%) knock-down efficiency of target gene in RNAi flies (F1’s) in 
comparison to wild type and parental lines (UAS and Gal4 constructs). RNA was isolated 
from whole-flies.  Analysis of transcript level was done using qRT-PCR results as described in 
the materials and methods method.   Data presented represent the mean ± SD of 2-3 independent 
experiments. 
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Tissues in 
which the 
target gene was 
knocked down 
 
 
Target 
Gene 
 
% knock-down 
efficiency of 
target gene in 
F1 progeny 
compared to  
wild-type (yw)  
controls 
 
% knockdown 
efficiency of 
target gene in 
F1  progeny 
compared to   
UAS construct 
(Parental line 
1) 
 
% knockdown 
efficiency of 
target gene in 
F1 progeny 
compared to   
Gal4 construct 
(Parental line 
2) 
 
Average % 
knockdown 
efficiency of 
target gene in 
F1 progeny 
compared to 
control flies 
Wings 
(MSO196-Gal4) 
CG6364 81 ±2 66 ± 6 81 ± 7 76 ± 9 
 
San 77 ± 7 82 ± 22 86 ± 14 82 ± 5 
 Body  
(MSO196-Gal4) 
CG6364 -26 ± 11 -8 ± 3 11 ± 2 -8 ± 19 
San - 41 17 20 34 ± 3 
 
Table 2.2  Comparison of knock-down efficiency in wing and whole body tissue wing-
specific  RNAi flies (F1’s) in comparison to wild type and parental lines (UAS and Gal4 
constructs). RNA was isolated from wings or fly body (without wings).  Analysis of transcript 
level was done using qRT-PCR results as described in the materials and methods method.   Data 
presented represent the mean ± SD of 2-3 independent experiments. 
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Tissues in 
which the 
target gene 
was knocked 
down 
 
 
Target 
Gene 
 
% knock-down 
efficiency of 
target gene in 
F1 progeny 
compared to  
wild-type (yw)  
controls 
 
% knockdown 
efficiency of 
target gene in 
F1  progeny 
compared to   
UAS construct 
(Parental line 1) 
 
% knockdown 
efficiency of 
target gene in 
F1 progeny 
compared to   
Gal4 construct 
(Parental line 
2) 
 
Average % 
knockdown 
efficiency of 
target gene in 
F1 progeny 
compared to 
control flies 
Whole heads 
(Gmr Gal4) 
CG6364 86 ± 4 88 ± 5. 89 ± 9 88 ± 2 
San 57 ± 2 85 ±7 81 ± 7 74 ±15 
 Body  
(Gmr Gal4) 
CG6364 23 ± 4 12 ± 3 8 ± 3 14 ± 8 
San 10 ± 0 25 ± 6 9 ± 3 15 ± 10 
 
Table 2.3 Comparison of knock-down efficiency in whole heads and whole body tissue of 
eye-specific RNAi flies (F1’s) in comparison to wild type and parental lines (UAS and Gal4 
constructs).  RNA was isolated from whole heads or fly body (without theads).  Analysis of 
transcript level was done using qRT-PCR results as described in the materials and methods 
method.   Data presented represent the mean ± SD of 2-3 independent experiments. 
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Tissues in 
which the 
target gene 
was knocked 
down 
 
 
Target 
Gene 
 
% knock-down 
efficiency of 
target gene in 
F1 progeny 
compared to  
wild-type (yw)  
controls 
 
% knockdown 
efficiency of 
target gene in 
F1  progeny 
compared to   
UAS construct 
(Parental line 1) 
 
% knockdown 
efficiency of 
target gene in 
F1 progeny 
compared to   
Gal4 construct 
(Parental line 
2) 
 
Average % 
knockdown 
efficiency of 
target gene in 
F1 progeny 
compared to 
controls 
Fat body 
 (YP1-Gal4) 
CG6364 75 85 70 77 ± 8 
San 79 57 62  66 ± 12 
 
Table 2.4 Comparison of knock-down efficiency in dissected fat body tissue of fat body-
specific RNAi third instar larvae (F1’s) in comparison to wild type and parental larvae 
(UAS and Gal4 constructs). RNA was isolated from dissected fat body tissue.  Analysis of 
transcript level was done using qRT-PCR as described in the materials and methods method.   
Data presented represent the mean ± SD of 1 independent experiment 
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Tissues in 
which the 
target gene 
was knocked 
down 
 
 
Target 
Gene 
 
% knockdown 
efficiency of 
target gene in 
F1 flies 
compared to  
wild type (yw)  
controls 
 
% knockdown 
efficiency of 
target gene in 
F1  progeny 
compared to   
UAS construct 
(Parental line 1) 
 
% knockdown 
efficiency of 
target gene in 
F1 progeny 
compared to   
Gal4 construct 
(Parental line 
2) 
 
Average % 
knockdown 
efficiency of 
target gene in 
F1 progeny 
compared to 
controls 
Salivary glands 
(Fhk-Gal4) 
CG6364 92 97 96 95 ± 2 
San 93 96 82 90 ± 6 
 Body  
(Fhk-Gal4) 
CG6364 16 32 36 28 ± 9 
San 18 22 30 23 ± 5 
 
Table 2.5 Comparison of knock-down efficiency in dissected salivary gland tissue of 
salivary gland-specific RNAi third instar larvae (F1’s) in comparison to wild type and 
parental larvae (UAS and Gal4 constructs).  RNA was isolated from dissected salivary gland 
tissue of whole larvae (without salivary gland).  Analysis of transcript level was done using qRT-
PCR as described in the materials and methods method.   Data presented represent the mean ± SD 
of 1 independent experiment 
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 Discussion/Conclusion 
       
The data presented in this thesis demonstrate that E. chaffeensis replicate in the 
hemocytes and fat body and fail to replicate in the eyes, wings or the salivary glands of adult D. 
melanogaster.  E. chaffeensis are transmitted from ticks to their hosts through the bite of ticks 
(26).  However, the tick system is not very well defined.  Therefore, we have used a genetically 
tractable system and defined the replication sites of E. chaffeensis in arthropods.  Although, fruit 
flies and ticks have different life-cycles the study provides insights to possible replication sites of 
E. chaffeensis in ticks.   
 
E. chaffeensis exhibits tropism for macrophages/ monocytes (26).  However, no clear 
tropism has been defined in ticks.  Consequently, establishing the replication sites in which this 
bacterium replicates in arthropod is important for complete understanding of the pathogenesis of 
the disease.  Hemocytes are the arthropod host equivalent of macrophages (19).  The fat body is 
functionally equivalent to mammalian liver (19).  Our data suggesting  that E. chaffeensis 
replicates in the hemocytes  is consistent with previous observation that Rickettsia rickettsii  
invade hemocytes in Ixodid ticks (35).  
 
            Previously, our group found that E. chaffeensis is capable of replicating in hemocyte-like 
phagocyic S2 cells (21).   S2 cells have hemocyte-like properties and express a variety of 
hemocyte-markers such as Hemolectin (Hml) (8), Hemese (He) (18), Drosophila scavenger 
receptor-CI (dSR-CI) (27) and croquemort, a member of the CD36 super family (16).  However, 
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the similarity of these cultured cells to hemocytes is an open question as evidences suggest that 
these cells have combined properties of plasmatocytes and crystal cells (9).  Therefore, the in 
vivo data confirms that E. chaffeensis replicate in the hemocytes of adult D. melanogaster.  This 
is consistent with the behavior of other intracellular pathogens are capable of avoiding the 
phagocytic pathway and replicate within Drosophila hemocytes.  These pathogens include 
Salmonella typhimurium (6), Listeria monocytogenes (24), Mycobacterium marinum (12), 
Legionella pneumophila (13), and Francisella tularensis (38).    
 
           E. chaffeensis did not replicate in the salivary gland of adult D. melanogaster.   These 
findings were intriguing since A.  phagocytophilum has been detected in the salivary glands 
experimentally infected  ticks (30).   In our experiments, Drosophila were infected in the 
abdomen with E. chaffeensis.  This is not similar to the natural route of infection in a tick.  Ticks 
acquire the infection by a blood meal (26).  Thus, the dissemination of E. chaffeensis to different 
tissues may vary due to differences in route of infection.   It may also be possible that salivary 
gland physiology may vary among arthropods depending on the life-cycle, which may account 
for inability of E. chaffeensis to grow in the salivary-glands of adult D. melanogaster.  
Moreover, Drosophila live on yeast growing on decaying fruit/food.  One may assume that they 
are better adapted to fight potential pathogenic micro-organisms in the salivary glands.   
 
Interestingly, we observed 97% fewer bacteria post 96 h of infection, in fat body-specific 
CG6364 or san- F1 RNAi flies compared to wild-type and parental controls. One might expect 
that because there is tissue-specific knock-down that some residual bacterial replication would 
occur.  Because this was not seen, the data suggest that E. chaffeensis were also incapable of 
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replicating within the hemocytes of the fat body-specific CG6364 and san-RNAi flies.  This 
observation suggests that there might be coordination between the hemocytes and the fat-body.   
In fact, several observations indicate that hemocytes can signal to the fat body to regulate the 
humoral immune response (3, 7, 11, 33).  Thus, signaling between the hemocytes and other 
immunocompetent tissue such as the fat body may play a critical role in coordinating the cellular 
and humoral immune response to ensure efficient defense of the organism. 
 
 The results in the thesis support that Ehrlichia replicate within the hemocytes of adult D. 
melanogaster.  Previously, our group also demonstrated that E. chaffeensis is capable of 
replicating in hemocyte-like phagocytic S2 cells (21).  These data support that the tissue-tropism 
of E. chaffeensis to phagocytic cells arose approximately 600 million years ago, since that is 
when mammals and dipterans last shared a common ancestor (17, 28).  It is not clear, however, 
whether this tropism will also be seen in A. americanum, the vector for E. chaffeensis.  Ticks and 
dipterans last shared a common ancestor approximately 500 million years ago (37).  Therefore, 
one would expect the tropism in hemocytes to be similar in ticks.  However, genetic drift could 
have occurred in the Ecdysozoa, Arthropoda or later in the Chelicerata (17).  Therefore, this 
hypothesis needs to be confirmed with experimental evidence. 
 
 The observation that E. chaffeensis is unable to replicate and cause infections in flies that 
had suppressed in CG6364 or san is consistent with previous findings using mutant flies.  
CG6364  is thought to be uridine/cytidine kinase (1).  Luce-Fedrow et al. found that 
supplementation of cytosine to S2 cell culture enhanced E. chaffeensis replication (20).  The 
investigators suggested that since cytidine is the least abundant nucleoside in cells, its use by 
Ehrlichia may be stressful on the host cell process which would make conditions amenable for E. 
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chaffeensis growth (20).  The human homolog of CG6364 is uridine cytidine kinase 2 (UCK2) 
(1).  The molecular function of san is defined as fatty acid binding/mitotic sister chromatid 
binding (2) and its human homolog is N(alpha)-acetyltransferase 50, NatE catalytic subunit for 
Drosophila san (2).  This can open avenues to finding homolog genes in humans that is a 
prerequisite for the bacteria to replicate. 
 
In conclusion, we have demonstrated that E. chaffensis replicates in the hemocytes and 
fat body of adult D. melanogaster.  The study has successfully identified the intracellular niches 
that E. chaffensis replicate within arthopods.   This provides insights to replication sites of E. 
chaffeensis in ticks.  Using an RNAi approach, we also confirmed the requirement of CG6364 
and san for in vivo E. chaffeensis replication.  Finding of conserved factors in humans from this 
investigation has a potential in translational research, immunodiagnostics, drug designing and 
RNAi therapeutics. 
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